Connor, Clark & Lunn Investment Management (CC&L)’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,808
| Closed | -$542K | – | 1494 |
|
|
2024
Q1 | $542K | Buy |
1,808
+374
| +26% | +$112K | ﹤0.01% | 1083 |
|
|
2023
Q4 | $338K | Sell |
1,434
-57
| -4% | -$13.4K | ﹤0.01% | 1145 |
|
|
2023
Q3 | $224K | Sell |
1,491
-71
| -5% | -$10.7K | ﹤0.01% | 1216 |
|
|
2023
Q2 | $272K | Sell |
1,562
-28
| -2% | -$4.87K | ﹤0.01% | 1127 |
|
|
2023
Q1 | $200K | Buy |
1,590
+937
| +143% | +$118K | ﹤0.01% | 1098 |
|
|
2022
Q4 | $198K | Buy |
+653
| New | +$198K | ﹤0.01% | 1056 |
|
|
2022
Q2 | – | Sell |
-899
| Closed | -$103K | – | 1102 |
|
|
2022
Q1 | $103K | Sell |
899
-295
| -25% | -$33.8K | ﹤0.01% | 974 |
|
|
2021
Q4 | $172K | Buy |
1,194
+71
| +6% | +$10.2K | ﹤0.01% | 996 |
|
|
2021
Q3 | $246K | Buy |
1,123
+59
| +6% | +$12.9K | ﹤0.01% | 914 |
|
|
2021
Q2 | $247K | Sell |
1,064
-215
| -17% | -$49.9K | ﹤0.01% | 883 |
|
|
2021
Q1 | $385K | Sell |
1,279
-4
| -0.3% | -$1.2K | ﹤0.01% | 825 |
|
|
2020
Q4 | $482K | Buy |
1,283
+152
| +13% | +$57.1K | ﹤0.01% | 730 |
|
|
2020
Q3 | $347K | Buy |
1,131
+192
| +20% | +$58.9K | ﹤0.01% | 769 |
|
|
2020
Q2 | $353K | Sell |
939
-368
| -28% | -$138K | ﹤0.01% | 819 |
|
|
2020
Q1 | $298K | Sell |
1,307
-19
| -1% | -$4.33K | ﹤0.01% | 800 |
|
|
2019
Q4 | $701K | Sell |
1,326
-9
| -0.7% | -$4.76K | ﹤0.01% | 609 |
|
|
2019
Q3 | $575K | Buy |
+1,335
| New | +$575K | ﹤0.01% | 651 |
|
|
2016
Q4 | – | Sell |
-138
| Closed | -$99K | – | 921 |
|
|
2016
Q3 | $99K | Sell |
138
-20
| -13% | -$14.3K | ﹤0.01% | 776 |
|
|
2016
Q2 | $115K | Sell |
158
-17
| -10% | -$12.4K | ﹤0.01% | 793 |
|
|
2016
Q1 | $104K | Sell |
175
-13
| -7% | -$7.73K | ﹤0.01% | 766 |
|
|
2015
Q4 | $108K | Buy |
188
+9
| +5% | +$5.17K | ﹤0.01% | 752 |
|
|
2015
Q3 | $100K | Buy |
179
+33
| +23% | +$18.4K | ﹤0.01% | 669 |
|
|
2015
Q2 | $116K | Buy |
146
+11
| +8% | +$8.74K | ﹤0.01% | 583 |
|
|
2015
Q1 | $112K | Buy |
+135
| New | +$112K | ﹤0.01% | 529 |
|